_ovarian-cancer-decisions-treatment-versus-maintenance-preview-1.jpg "Ovarian Cancer Decisions: Treatment Versus Maintenance from niparinib versus imgn 853 Video Screenshot Preview 1")
Gallery_ovarian-cancer-decisions-treatment-versus-maintenance-preview-3.jpg "Ovarian Cancer Decisions: Treatment Versus Maintenance from niparinib versus imgn 853 Video Screenshot Preview 3")
Gallery_ovarian-cancer-decisions-treatment-versus-maintenance-preview-hqdefault.jpg "Ovarian Cancer Decisions: Treatment Versus Maintenance from niparinib versus imgn 853 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 52 seconds
👁 View: 285 times
Play Audio:👁 View: 285 times
Description:
OncLiveTV
OncLiveTV
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_dr-mirza-on-niraparib-plus-bevacizumab-combo-in-ovarian-cancer.webp "OncLiveTV")
_immunotherapy-amp-ovarian-cancer.webp "Ovarian Cancer Action UK")
_dr-penson-on-olaparib-monotherapy-vs-chemo-for-ovarian-cancer.webp "OncLiveTV")
_dr-matulonis-on-individualized-dosing-of-niraparib-in-ovarian-cancer.webp "OncLiveTV")
_what-is-a-parp-inhibitor-124-dana-farber-cancer-institute-124-science-illustrated.webp "Dana-Farber Cancer Institute")
⏲ 2 minutes 47 seconds 👁 38.2K
_dr-mirza-on-niraparib-plus-bevacizumab-combo-in-ovarian-cancer.jpg)
_immunotherapy-amp-ovarian-cancer.jpg)
_dr-penson-on-olaparib-monotherapy-vs-chemo-for-ovarian-cancer.jpg)
_dr-matulonis-on-individualized-dosing-of-niraparib-in-ovarian-cancer.jpg)
_what-is-a-parp-inhibitor-124-dana-farber-cancer-institute-124-science-illustrated.jpg)
![[+]](/images/menu.gif){kind=small}